The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Identification of Innate IL-5–Producing Cells and Their Role in Lung Eosinophil Regulation and Antitumor Immunity
Open accessAbstract
IL-5 is involved in a number of immune responses such as helminth infection and allergy. IL-5 also plays roles in innate immunity by maintaining B-1 B cells and mucosal IgA production. However, the identity of IL-5–producing cells has not been unambiguously characterized. In this report, we describe the generation of an IL-5 reporter mouse and identify IL-5–producing non-T lymphoid cells that reside in the intestine, peritoneal cavity, and lungs in naive mice. They share many characteristics with natural helper cells, nuocytes, and Ih2 cells, including surface Ags and responsiveness to cytokines. However, these phenotypes do not completely overlap with any particular one of these cell types. Innate non-T IL-5–producing cells localized most abundantly in the lung and proliferated and upregulated IL-5 production in response to IL-25 and IL-33. IL-33 was more effective than IL-25. These cells contribute to maintaining sufficient numbers of lung eosinophils and are important for eosinophil recruitment mediated by IL-25 and IL-33. Given that eosinophils are shown to possess antitumor activity, we studied lung tumor metastasis and showed that innate IL-5–producing cells were increased in response to tumor invasion, and their regulation of eosinophils is critical to suppress tumor metastasis. Genetic blockade or neutralization of IL-5 impaired eosinophil recruitment into the lung and resulted in increased tumor metastasis. Conversely, exogenous IL-5 treatment resulted in suppressed tumor metastasis and augmented eosinophil infiltration. These newly identified innate IL-5–producing cells thus play a role in tumor surveillance through lung eosinophils and may contribute to development of novel immunotherapies for cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagai, T., Ibata, K., Park, E. S., Kubota, M., Mikoshiba, K., & Miyawaki, A. (2002) · Nature Biotechnology · doi:10.1038/nbt0102-87 · Cited by 2,753
Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H., Furusawa, J.-I., Ohtani, M., Fujii, H., & Koyasu, S. (2010) · Nature · doi:10.1038/nature08636 · Cited by 1,992
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
Haldar, P., Brightling, C. E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R. P., Bradding, P., Green, R. H., Wardlaw, A. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808991 · Cited by 1,871
Mepolizumab for Prednisone-Dependent Asthma with Sputum Eosinophilia
Nair, P., Pizzichini, M. M. M., Kjarsgaard, M., Inman, M. D., Efthimiadis, A., Pizzichini, E., Hargreave, F. E., & O'Byrne, P. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0805435 · Cited by 1,356
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Systemically dispersed innate IL-13–expressing cells in type 2 immunity
Price, A. E., Liang, H.-E., Sullivan, B. M., Reinhardt, R. L., Eisley, C. J., Erle, D. J., & Locksley, R. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003988107 · Cited by 1,131
Murine interleukin-4 displays potent anti-tumor activity in vivo
Tepper, R. I., Pattengale, P. K., & Leder, P. (1989) · Cell · doi:10.1016/0092-8674(89)90925-2 · Cited by 778
A Study to Evaluate Safety and Efficacy of Mepolizumab in Patients with Moderate Persistent Asthma
Flood-Page, P., Swenson, C., Faiferman, I., Matthews, J., Williams, M., Brannick, L., Robinson, D., Wenzel, S., Busse, W., Hansel, T. T., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-085oc · Cited by 750
Fallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., & McKenzie, A. N. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051615 · Cited by 738
Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S., Seymour, B., Jackson, C., Kung, T. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.443 · Cited by 619
Kopf, M., Brombacher, F., Hodgkin, P. D., Ramsay, A. J., Milbourne, E. A., Dai, W. J., Ovington, K. S., Behm, C. A., Köhler, G., Young, I. G., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80294-0 · Cited by 594
Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab
Rothenberg, M. E., Klion, A. D., Roufosse, F. E., Kahn, J. E., Weller, P. F., Simon, H.-U., Schwartz, L. B., Rosenwasser, L. J., Ring, J., Griffin, E. F., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070812 · Cited by 583
IL25 elicits a multipotent progenitor cell population that promotes TH2 cytokine responses
Saenz, S. A., Siracusa, M. C., Perrigoue, J. G., Spencer, S. P., Urban Jr, J. F., Tocker, J. E., Budelsky, A. L., Kleinschek, M. A., Kastelein, R. A., Kambayashi, T., et al. (2010) · Nature · doi:10.1038/nature08901 · Cited by 555
An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4
Tepper, R. I., Coffman, R. L., & Leder, P. (1992) · Science · doi:10.1126/science.1636093 · Cited by 541
Yamaguchi, Y., Suda, T., Suda, J., Eguchi, M., Miura, Y., Harada, N., Tominaga, A., & Takatsu, K. (1988) · The Journal of experimental medicine · doi:10.1084/jem.167.1.43 · Cited by 514
Self-citationA novel IL-1 family cytokine, IL-33, potently activates human eosinophils
Cherry, W. B., Yoon, J., Bartemes, K. R., Iijima, K., & Kita, H. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.005 · Cited by 499
Sakai, K., & Miyazaki, J.-I. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7111 · Cited by 493
Distinct Role of Antigen-Specific T Helper Type 1 (Th1) and Th2 Cells in Tumor Eradication in Vivo
Nishimura, T., Iwakabe, K., Sekimoto, M., Ohmi, Y., Yahata, T., Nakui, M., Sato, T., Habu, S., Tashiro, H., Sato, M., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.5.617 · Cited by 468
Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
Simon, H. U., Yousefi, S., Schranz, C., Schapowal, A., Bachert, C., & Blaser, K. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3902 · Cited by 468
Eosinophil trafficking in allergy and asthma
Rosenberg, H. F., Phipps, S., & Foster, P. S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.048 · Cited by 428
Kinashi, T., Harada, N., Severinson, E., Tanabe, T., Sideras, P., Konishi, M., Azuma, C., Tominaga, A., Bergstedt-Lindqvist, S., Takahashi, M., et al. (1986) · Nature · doi:10.1038/324070a0 · Cited by 398
Self-citationCD4+T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ
Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D., & Schreiber, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8633 · Cited by 384
Takatsu, K., & Nakajima, H. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.001 · Cited by 320
Self-citationIL-13 induces eosinophil recruitment into the lung by an IL-5– and eotaxin-dependent mechanism
Pope, S. M., Brandt, E. B., Mishra, A., Hogan, S. P., Zimmermann, N., Matthaei, K. I., Foster, P. S., & Rothenberg, M. E. (2001) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2001.118600 · Cited by 314
Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y., Hosoya, Y., Yamauchi, S., & Kanai, Y. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.2.429 · Cited by 298
Self-citationImmunotherapy of Cytotoxic T Cell–resistant Tumors by T Helper 2 Cells
Mattes, J., Hulett, M., Xie, W., Hogan, S., Rothenberg, M. E., Foster, P., & Parish, C. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021683 · Cited by 256
Inhibition of Angiogenesis by Interleukin 4
Volpert, O. V., Fong, T., Koch, A. E., Peterson, J. D., Waltenbaugh, C., Tepper, R. I., & Bouck, N. P. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1039 · Cited by 255
Horiuchi, T., & Weller, P. F. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.1.2796 · Cited by 238
Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue
Nielsen, H. J., Hansen, U., Christensen, I. J., Reimert, C. M., Br�nner, N., Moesgaard, F., & The RANX05 Study Group (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199912)189:4<487::aid-path484>3.0.co;2-i · Cited by 233
Simson, L., Ellyard, J. I., Dent, L. A., Matthaei, K. I., Rothenberg, M. E., Foster, P. S., Smyth, M. J., & Parish, C. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.7.4222 · Cited by 216
Yoshida, T., Ikuta, K., Sugaya, H., Maki, K., Takagi, M., Kanazawa, H., Sunaga, S., Kinashi, T., Yoshimura, K., Miyazaki, J.-I., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80414-8 · Cited by 214
Self-citationRole of IL-13 in regulation of anti-tumor immunity and tumor growth
Terabe, M., Park, J. M., & Berzofsky, J. A. (2004) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-003-0445-0 · Cited by 210
Identification of eosinophil lineage–committed progenitors in the murine bone marrow
Iwasaki, H., Mizuno, S.-I., Mayfield, R., Shigematsu, H., Arinobu, Y., Seed, B., Gurish, M. F., Takatsu, K., & Akashi, K. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050548 · Cited by 207
Self-citationInnate immune cell populations function as initiators and effectors in Th2 cytokine responses
Saenz, S. A., Noti, M., & Artis, D. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.09.001 · Cited by 177
Cormier, S. A., Taranova, A. G., Bedient, C., Nguyen, T., Protheroe, C., Pero, R., Dimina, D., Ochkur, S. I., O’Neill, K., Colbert, D., et al. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106027 · Cited by 176
Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas
Dorta, R. G., Landman, G., Kowalski, L. P., Lauris, J. R. P., Latorre, M. R. D. O., & Oliveira, D. T. (2002) · Histopathology · doi:10.1046/j.1365-2559.2002.01437.x · Cited by 161
The Role of IL-5 for Mature B-1 Cells in Homeostatic Proliferation, Cell Survival, and Ig Production
Moon, B.-G., Τακακι, S., Miyake, K., & Takatsu, K. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6020 · Cited by 148
Self-citationYang, M., Hogan, S. P., Mahalingam, S., Pope, S. M., Zimmermann, N., Fulkerson, P. C., Dent, L. A., Young, I. G., Matthaei, K. I., Rothenberg, M. E., et al. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.08.010 · Cited by 117
Harada, N., Takahashi, T., Matsumoto, M., Kinashi, T., Ohara, J., Kikuchi, Y., Koyama, N., Gronowicz, E. S., Yaoita, Y., & Honjo, T. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.13.4581 · Cited by 96
Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice
Zhiguang, X., Chen, W., Steven, R., Dong, W., Zhang, W., Mu, R., Zhanguo, L., & Zhang, L. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.04.005 · Cited by 85
Interleukin-5 and the regulation of eosinophil production
Roboz, G. J., & Rafii, S. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199905000-00007 · Cited by 72
Shimada, H., Newton, W. A., Soule, E. H., Beltangady, M. S., & Maurer, H. M. (1987) · Cancer · doi:10.1002/1097-0142(19870201)59:3<466::aid-cncr2820590319>3.0.co;2-p · Cited by 71
Regulation of Eosinophil Migration and Th2 Cell Function by IL-5 and Eotaxin
Mattes, J., & Foster, P. S. (2003) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010033484214 · Cited by 56
Olver, S. D., Apte, S. H., Baz, A., & Kienzle, N. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00831.x · Cited by 40
Molecules Involved in the Regulation of Eosinophil Apoptosis
Simon, H. (2005) · KARGER eBooks · doi:10.1159/000090229 · Cited by 39
Cited by
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945
“By inducing IL-5 production in several cell types, ILCs in particular, and by promoting eosinophil maturation, IL-33 causes eosinophilia in vivo (Bouffi et al., 2013; Ikutani et al., 2012; Pecaric-Petkovic et al., 2009).”
Type 2 innate lymphoid cells control eosinophil homeostasis
Nussbaum, J. C., Van Dyken, S. J., von Moltke, J., Cheng, L. E., Mohapatra, A., Molofsky, A. B., Thornton, E. E., Krummel, M. F., Chawla, A., Liang, H.-E., et al. (2013) · Nature · doi:10.1038/nature12526 · Cited by 1,068
Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity
Mantovani, A., Dinarello, C. A., Molgora, M., & Garlanda, C. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.012 · Cited by 1,046
Natural killer cells and other innate lymphoid cells in cancer
Chiossone, L., Dumas, P.-Y., Vienne, M., & Vivier, E. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0061-z · Cited by 1,007
Eosinophils: changing perspectives in health and disease
Rosenberg, H. F., Dyer, K. D., & Foster, P. S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3341 · Cited by 989
Metadata
- Authors
- Ikutani, M., Yanagibashi, T., Ogasawara, M., Tsuneyama, K., Yamamoto, S., Hattori, Y., Kouro, T., Itakura, A., Nagai, Y., Takaki, S., & Takatsu, K.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-01
- Volume
- 188
- Issue
- 2
- Pages
- 703-713
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125573114
- Cited by
- 314
- References
- 47
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.